Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Steinbrunn, T; Stuhmer, T; Gattenlohner, S; Rosenwald, A; Mottok, A; Unzicker, C; Einsele, H; Chatterjee, M; Bargou, RC.
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival.
Blood. 2011; 117(6):1998-2004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Gattenlöhner Stefan

Dimensions Citations:

Plum Analytics:
We have recently shown that approximately half of primary multiple myeloma (MM) samples display constitutive Akt activity, which disposes them for sensitivity to Akt inhibition. The Akt pathway counts among the signaling conduits for oncogenic RAS and activating mutations of K- and N-RAS frequently occur in MM. We therefore analyzed the relation between RAS mutation and Akt dependency in biopsies and CD138-purified cells from MM patients (n = 65) and the function of oncogenic RAS for MM cell survival in a range of MM cell lines with differing RAS status. Whereas RAS mutations do not predict Akt dependency, oncogenic RAS retains an important role for MM cell survival. Knockdown of either K- or N-RAS strongly decreased the viability of MM cells that harbored the respective oncogenic isoform, whereas ablation of wild-type RAS isoforms had little or no effect. Silencing of oncogenic RAS did not affect the Akt pathway, again indicating lack of a direct link. Combined inhibition of RAS and Akt strongly enhanced MM cell death. These data suggest that oncogenic RAS and Akt may independently contribute to MM cell survival. Targeting of both pathways could provide an attractive therapeutic strategy for patients with oncogenic RAS and dysregulated Akt signaling.
Find related publications in this database (using NLM MeSH Indexing)
Base Sequence -
Cell Line, Tumor -
Cell Survival -
DNA Primers - genetics
Gene Knockdown Techniques -
Genes, ras -
Humans -
MAP Kinase Signaling System -
Multiple Myeloma - genetics
Mutation -
Proto-Oncogene Proteins c-akt - metabolism
RNA, Small Interfering - genetics
Signal Transduction -

© Med Uni Graz Impressum